Related references
Note: Only part of the references are listed.Gene modulation and immunoregulatory roles of Interferonγ
Banishree Saha et al.
CYTOKINE (2010)
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Gu,rin (BCG) immunotherapy for urothelial carcinoma of the bladder
Henry M. Rosevear et al.
CANCER AND METASTASIS REVIEWS (2009)
Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy
Vincent Flacher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Intracellular concentrations of Ca2+ modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4+ T lymphocytes
Asma Ahmed et al.
IMMUNOLOGY (2009)
Immunogenicity and Protective Efficacy of Mycobacterium w against Mycobacterium tuberculosis in Mice Immunized with Live versus Heat-Killed M. w by the Aerosol or Parenteral Route
Ankan Gupta et al.
INFECTION AND IMMUNITY (2009)
Thymoma A Focus on Current Therapeutic Management
Nicolas Girard et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct Species
Vikram Saini et al.
PLOS ONE (2009)
Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
Stefan Nierkens et al.
PLOS ONE (2009)
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung
J. L. Stanford et al.
EUROPEAN JOURNAL OF CANCER (2008)
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
P. M. Patel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Disseminated Bacillus CalmetteGuerin Infection after BCG Vaccination
Mohammad Sadegh Rezai et al.
JOURNAL OF TROPICAL PEDIATRICS (2008)
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
Enrique M. Ocio et al.
LANCET ONCOLOGY (2008)
The use of mycobacterial adjuvant-based agents for immunotherapy of cancer
J. M. Grange et al.
VACCINE (2008)
Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis
K. Katoch et al.
VACCINE (2008)
Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes
V Abadie et al.
BLOOD (2005)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cell surface expression:: roles of TAP, Tapasin and β2-microglobulin
SJ Prasanna et al.
MOLECULAR IMMUNOLOGY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer:: phase III results
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis
J Stanford et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Immunodeficient mouse models of lymphoid tumors
K Imada
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Production of interferon-gamma by tumor-sensitized T cells is essential for interleukin-12-induced complete tumor eradication
NC Lee et al.
SURGERY (2002)
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells
WC Cheung et al.
LEUKEMIA (2002)
Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms
S Kakuta et al.
IMMUNOLOGY (2002)
IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer
J Riemensberger et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton
M Matsumoto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Eradication of established tumors by CD8+ T cell adoptive immunotherapy
HL Hanson et al.
IMMUNITY (2000)
Share Paper
